Although SARS-CoV-2 genetic material may still be detected in respiratory or stool samples for several weeks, no live virus (that can cause infection) was found in any type of sample collected beyond nine days of symptoms ...
Nov 20, 2020
0
183
There is a growing need for new antibiotics to help combat the looming threat of antimicrobial resistance. According to a new study conducted by researchers at the Center for Disease Dynamics, Economics & Policy (CDDEP) with ...
Oct 16, 2018
0
4
Using inhaled antibiotics to treat lower respiratory tract infections could help reduce antimicrobial resistance, according to researchers from the Universities of Bristol and Bath.
May 13, 2022
0
117
Respiratory tract infections, including pneumonia, are the most common cause of death in children under the age of five. In a study looking at children given standard antibiotic therapy, new research published in BioMed Central's ...
Feb 8, 2012
0
1
(HealthDay)—The U.S. Food and Drug Administration late Friday approved three new medications to help people battle type 2 diabetes.
Jan 26, 2013
1
3
An international study led by University of Queensland (UQ) researchers has tracked the re-emergence of a childhood disease which had largely disappeared over the past 100 years.
Nov 4, 2015
0
73
Nirsevimab showed 74.5 percent efficacy against medically attended lower respiratory tract infections caused by respiratory syncytial virus (RSV) in healthy infants, according to an international, randomized, placebo-controlled ...
Mar 2, 2022
0
788
Antibiotics are lifesaving drugs, but overuse is leading to one of the world's most pressing health threats: antibiotic resistance. Researchers at the University of Rochester Medical Center are developing a tool to help physicians ...
Jul 28, 2017
0
109
Because whooping cough (pertussis) is almost as contagious as measles (affecting ~12-17 individuals with each case), clinicians are required to report cases of this bacterial respiratory tract infection to the state's department ...
Jul 19, 2012
0
0
(HealthDay)—Vyvgart (efgartigimod), a neonatal Fc receptor blocker (FcRn), was approved to treat generalized myasthenia gravis in adults who test positive for the anti-acetylcholine receptor (AChR) antibody, the U.S. Food ...
Dec 21, 2021
0
6
